Accumulating evidence shows that metformin, utilized as an antidiabetic drug, possesses anti-cancer properties

Accumulating evidence shows that metformin, utilized as an antidiabetic drug, possesses anti-cancer properties. by increasing both autophagy and apoptosis; moreover, it impacts the success of cultured cells inhibiting the transcriptional activation of Nuclear element E2-related element 2 (NRF-2) and nuclear factor-kappa B (NF-B). The consequences of metformin on HT29 cells had been dose- and time-dependent. … Continue reading Accumulating evidence shows that metformin, utilized as an antidiabetic drug, possesses anti-cancer properties